Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Dept Of Ophthalmology, |
RCV003887979 | SCV004707750 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Ambry Genetics | RCV004035451 | SCV004937582 | uncertain significance | Inborn genetic diseases | 2024-01-24 | criteria provided, single submitter | clinical testing | The c.313A>G (p.I105V) alteration is located in exon 5 (coding exon 3) of the RDH12 gene. This alteration results from a A to G substitution at nucleotide position 313, causing the isoleucine (I) at amino acid position 105 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001277611 | SCV001464575 | uncertain significance | Leber congenital amaurosis | 2020-04-17 | no assertion criteria provided | clinical testing |